SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Liang Hong

(Last) (First) (Middle)
2631 HANOVER STREET

(Street)
PALO ALTO CA 94304

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
10/03/2018
3. Issuer Name and Ticker or Trading Symbol
Kodiak Sciences Inc. [ KOD ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
See Remarks
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 20,000 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) (1) 06/23/2026 Common Stock 112,000 1.04 D
Stock Option (Right to Buy) (2) 05/16/2027 Common Stock 20,000 1.06 D
Stock Option (Right to Buy) (3) 04/04/2028 Common Stock 99,800 5.38 D
Stock Option (Right to Buy) (4) 04/04/2028 Common Stock 74,300 5.38 D
Explanation of Responses:
1. The Reporting Person was originally granted an option to purchase 132,000 shares. Twenty-Five percent of the shares subject to the option vested on December 7, 2016, and 1/48th of the shares subject to the option vest on the same day of each month thereafter. On August 30, 2018, the Reporting Person exercised 20,000 of those shares.
2. One-forty-eighth of the shares subject to the option vested on May 15, 2017, and 1/48th of the shares subject to the option vest on the same day of each month thereafter.
3. One-forty-eighth of the shares subject to the option vested on April 1, 2018, and 1/48th of the shares subject to the option vest on the same day of each month thereafter.
4. One-forty-eighth of the shares subject to the option vested on November 30, 2017, and 1/48th of the shares subject to the option vest on the same day of each month thereafter.
Remarks:
Senior Vice President, Discovery Medicine Power of Attorney
Barbara A. Mery, Attorney in fact for Hong Liang 10/03/2018
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
                                   POWER OF ATTORNEY

       The undersigned, as a Section 16 reporting person of Kodiak Sciences Inc.
(the "Company"), hereby constitutes and appoints each of the responsible
attorneys and paralegals of Wilson Sonsini Goodrich & Rosati, Professional
Corporation, the undersigned's true and lawful attorney-in-fact to:

       1.   complete and execute Forms ID, 3,4 and 5 and other forms and all
            amendments thereto as such attorney-in-fact shall in his or her
            discretion determine to be required or advisable pursuant to Section
            16 of the Securities Exchange Act of 1934 (as amended) and the rules
            and regulations promulgated thereunder, or any successor laws and
            regulations, as a consequence of the undersigned's ownership,
            acquisition or disposition of securities of the Company; and

       2.   do all acts necessary in order to file such forms with the
            Securities and Exchange Commission, any securities exchange or
            national association, the Company and such other person or agency as
            the attorney-in-fact shall deem appropriate.

       The undersigned hereby ratifies and confirms all that said attorneys-in-
fact and agents shall do or cause to be done by virtue hereof.  The undersigned
acknowledges that the foregoing attorneys-in-fact, in serving in such
 capacity
at the request of the undersigned, are not assuming, nor is the Company
assuming, any of the undersigned's responsibilities to comply with Section 16 of
the Securities Exchange Act of 1934 (as amended).

       This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms ID, 3, 4 and 5 with respect to
the undersigned's holdings of and transactions in securities issued by the
Company, unless earlier revoked by the undersigned in a signed writing delivered
to the Company and the foregoing attorneys-in-fact.

       IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of September 24, 2018.


                                        Signature:  /s/ Hong Liang
                                                    --------------------
                                                    Hong Liang